{"id":"W4414853478","doi":"10.1038/s41408-025-01356-z","title":"Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Pomalidomide; Dexamethasone; Cyclophosphamide; Multiple myeloma; Clinical endpoint; Adverse effect; Lenalidomide; Refractory (planetary science)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004929173,0.0008295342,0.003239621,0.00110135,0.0004506057,0.0001524061,0.000672837,0.0002930877,0.0006725574],"category_scores_gemma":[0.002976831,0.0006202009,0.0004761021,0.002236772,0.0003073188,0.0004966995,0.0002461753,0.001785841,0.000008762616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007464833,"about_ca_system_score_gemma":0.002055837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003149262,"about_ca_topic_score_gemma":0.006496045,"domain_scores_codex":[0.9900514,0.003301663,0.002491976,0.001072022,0.001632014,0.001450943],"domain_scores_gemma":[0.9942473,0.001858711,0.001024045,0.00122479,0.0006499322,0.0009952612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7000724,0.03456113,0.1938758,0.0001184106,0.007928003,0.00895822,0.002969894,0.0002581147,0.0006862185,0.00001960266,0.0003419504,0.05021028],"study_design_scores_gemma":[0.8266015,0.0146173,0.1431207,0.0007786341,0.003532615,0.0002155859,0.009039669,0.0002378463,0.001084184,0.00008475559,0.0002086838,0.0004785533],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838741,0.007318167,0.00009138195,0.000376873,0.001301942,0.00598088,0.00003091979,0.00008497597,0.0009407289],"genre_scores_gemma":[0.9932522,0.001626955,0.002297712,0.0001276486,0.0007284002,0.0008498986,0.0000214991,0.0001160015,0.0009796537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1265291,"threshold_uncertainty_score":0.9996249,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04355623544536998,"score_gpt":0.3898106288010451,"score_spread":0.3462543933556751,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}